New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
10:16 EDTXOMA, JOE, DKS, TDC, TKMR, DRTX, XPO, HMSY, BCORHigh option volume stocks
High option volume stocks: TKMR JOE HMSY TDC XOMA XPO VGK DKS BCOR DRTX
News For TKMR;JOE;HMSY;TDC;XOMA;XPO;DKS;BCOR;DRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 30, 2015
06:02 EDTXOMAStocks with implied volatility above IV index mean; YELP XOMA
Subscribe for More Information
June 29, 2015
10:04 EDTJOEHigh option volume stocks
Subscribe for More Information
05:51 EDTXOMAStocks with implied volatility movement; XOMA EXEL
Subscribe for More Information
June 26, 2015
17:53 EDTXPOXPO Logistics says ND is subject of ongoing investigation by French regulators
XPO Logistics said in a regulatory filing that ND or Norbert Dentressangle is subject to an ongoing investigation by the French Competition Authority. On June 8, XPO Logistics announced that it has consummated the previously announced agreement to purchase all of the shares of Norbert Dentressangle held by Mr. Norbert Dentressangle and his family, representing 67% of the company's outstanding shares, at a price of 217.50 euros per share. XPO continued in a filing: "In July 2014, ND Distribution received notification from the French antitrust authorities relating to alleged anti-competitive practices of companies in the parcel express delivery business. Most French companies participating in this market also received complaints covering several prior years. The investigation focuses on the role played by an industry syndicate, in which the participants are said to have exploited the syndicate’s “Pooling Business Advisory” meetings so as to align their sales practices and, in particular, prices. The French antitrust authorities are reviewing the period from June 2007 to March 2008, which straddles the period during which ND completed its indirect takeover of ND Distribution. ND expects that a hearing may be held late in 2015 or early in 2016. Additionally, ND is involved in certain proceedings in the Valence Criminal Court regarding a two-year preliminary enquiry into the way ND organizes international transport sub-contracting operations. No provision has been made in ND’s financial statements regarding either investigation, and while ND disputes the claims against it, any adverse findings or decisions arising out of such investigation could have a material adverse impact on ND’s business and financial condition. "
09:41 EDTXOMAXOMA mentioned positively by Biotech Insider
06:05 EDTXOMAStocks with implied volatility above IV index mean; XOMA NBG
Subscribe for More Information
June 25, 2015
05:57 EDTXOMAStocks with implied volatility above IV index mean; XOMA YELP
Subscribe for More Information
June 24, 2015
15:53 EDTDKSSunTrust identifies the most likely M&A activity in specialty retail
Subscribe for More Information
05:57 EDTXOMAStocks with implied volatility above IV index mean; XOMA THC
Stocks with implied volatility above IV index mean; XOMA (XOMA) 169, Tenet (THC) 51 according to iVolatility.
June 23, 2015
05:57 EDTXOMAStocks with implied volatility above IV index mean; XOMA YELP
Subscribe for More Information
June 22, 2015
14:08 EDTXOMAXOMA calls active as shares rally
Subscribe for More Information
June 19, 2015
14:33 EDTTKMRTekmira main driver still hepatitis B program, says Leerink
Subscribe for More Information
10:00 EDTXPOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:18 EDTTKMROn The Fly: Pre-market Movers
Subscribe for More Information
08:01 EDTTKMRTekmira provides update on TKM-Ebola-Guinea
Tekmira Pharmaceuticals announced that the Phase II clinical trial of TKM-Ebola-Guinea has reached a predefined statistical endpoint and enrollment has been closed. The endpoint indicated that continuing enrollment was not likely to demonstrate an overall therapeutic benefit. Data analysis is ongoing and the full results will be made available as soon as possible. In this trial, TKM-Ebola-Guinea is being evaluated for efficacy in Ebola virus infected patients in Sierra Leone, West Africa. The Phase II single arm trial called RAPIDE, or Rapid Assessment of Potential Interventions & Drugs for Ebola, is open-label with a concurrent observational study of Ebola virus disease in Sierra Leone.
07:08 EDTXPOXPO Logistics initiated with an Outperform at William Blair
Subscribe for More Information
June 18, 2015
10:01 EDTHMSYOn The Fly: Analyst Initiation Summary
Subscribe for More Information
June 17, 2015
16:21 EDTHMSYHMS Holdings initiated with an Outperform at Oppenheimer
Target $20.
09:03 EDTTDCVoltDB announces new partnership agreement with Teradata
Subscribe for More Information
June 16, 2015
09:06 EDTXOMAXOMA receives ODD for XOMA 358 from FDA
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use